Mandeep Chawla sold $6.8M of CLS
Chief Financial Officer at CELESTICA INC. 17,000 shares at an average of $399.65, traded Jun 15, 2026, filed Jun 17, 2026.
Score components
- +22RoleCFO
- +25Trade size$6.8M at market
- +5Share of holdings soldSold 17% of holdings
- +8Cluster2 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-274659, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -200 | $394.25 | $79k | 99,244 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -212 | $395.41 | $84k | 99,032 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -848 | $396.24 | $336k | 98,184 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -1,661 | $397.32 | $660k | 96,523 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -3,788 | $398.29 | $1.5M | 92,735 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -3,607 | $399.22 | $1.4M | 89,128 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -1,240 | $400.20 | $496k | 87,888 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -1,508 | $401.30 | $605k | 86,380 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -2,919 | $402.21 | $1.2M | 83,461 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -697 | $402.93 | $281k | 82,764 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -40 | $403.79 | $16k | 82,724 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -40 | $405.77 | $16k | 82,684 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -120 | $406.82 | $49k | 82,564 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -80 | $408.88 | $33k | 82,484 | Jun 17, 2026 |
| Jun 15, 2026 | SOpen-market sale Common Shares10b5-1 | -40 | $412.99 | $17k | 82,444 | Jun 17, 2026 |
Related signals
Other insiders at CELESTICA INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $8.5M 23,396 shares | -100% | |
| 38Weak | CELESTICA INC | Todd C Cooper President | $7.2M 20,118 shares | -22% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $8.5M 23,496 shares | -50% | |
| 40Moderate | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $6.0M 16,117 shares | -20% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $36M 98,453 shares | -194% | |
| 58Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $19M 51,061 shares | -52% | |
| 24Weak | CELESTICA INC | Mandeep Chawla Chief Financial Officer | $324k 883 shares | -1% | |
| 43Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $3.5M 9,543 shares | -16% | |
| 48Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $26M 66,056 shares | -33% | |
| 48Moderate | CELESTICA INC | Robert Mionis Chief Executive Officer | $22M 55,768 shares | -42% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.